EGFR and colorectal carcinoma: Upon BRAF ± EGFR inhibition, SRC-dependent phosphorylation of Y654 increases β-catenin’s transcriptional activity, leading to a reprogramming of the transcriptional profiles of BRAFV600E CRC cells.